- Home
- DCTH vs CUB Comparison
DCTH vs CUB Comparison
Compare DCTH & CUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- CUB
- Stock Information
- Founded
- DCTH 1988
- CUB 2024
- Country
- DCTH United States
- CUB United States
- Employees
- DCTH N/A
- CUB N/A
- Industry
- DCTH Medical/Dental Instruments
- CUB
- Sector
- DCTH Health Care
- CUB
- Exchange
- DCTH Nasdaq
- CUB NYSE
- Market Cap
- DCTH 379.5M
- CUB 307.3M
- IPO Year
- DCTH N/A
- CUB 2024
- Fundamental
- Price
- DCTH $11.80
- CUB $10.07
- Analyst Decision
- DCTH Strong Buy
- CUB
- Analyst Count
- DCTH 4
- CUB 0
- Target Price
- DCTH $21.50
- CUB N/A
- AVG Volume (30 Days)
- DCTH 389.0K
- CUB 17.7K
- Earning Date
- DCTH 11-08-2024
- CUB 01-01-0001
- Dividend Yield
- DCTH N/A
- CUB N/A
- EPS Growth
- DCTH N/A
- CUB N/A
- EPS
- DCTH N/A
- CUB N/A
- Revenue
- DCTH $22,644,000.00
- CUB N/A
- Revenue This Year
- DCTH $1,605.13
- CUB N/A
- Revenue Next Year
- DCTH $111.67
- CUB N/A
- P/E Ratio
- DCTH N/A
- CUB N/A
- Revenue Growth
- DCTH 945.91
- CUB N/A
- 52 Week Low
- DCTH $3.10
- CUB $9.96
- 52 Week High
- DCTH $12.88
- CUB $10.55
- Technical
- Relative Strength Index (RSI)
- DCTH 58.11
- CUB N/A
- Support Level
- DCTH $11.48
- CUB N/A
- Resistance Level
- DCTH $12.10
- CUB N/A
- Average True Range (ATR)
- DCTH 0.70
- CUB 0.00
- MACD
- DCTH 0.07
- CUB 0.00
- Stochastic Oscillator
- DCTH 71.39
- CUB 0.00
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
About CUB LIONHEART HOLDINGS
Lionheart Holdings is a blank check company.